ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
复制标题
DOI:
10.1038/s41590-023-01513-1
复制
发表时间:
2023-07
影响因子:
30.5
通讯作者:
Alter, Galit
中科院分区:
文献类型:
--
作者:
Kaplonek, Paulina;Cizmeci, Deniz;Kwatra, Gaurav;Izu, Alane;Lee, Jessica Shih-Lu;Bertera, Harry L.;Fischinger, Stephanie;Mann, Colin;Amanat, Fatima;Wang, Wenjun;Koen, Anthonet L.;Fairlie, Lee;Cutland, Clare L.;Ahmed, Khatija;Dheda, Keertan;Barnabas, Shaun L.;Bhorat, Qasim Ebrahim;Briner, Carmen;Krammer, Florian;Saphire, Erica Ollman;Gilbert, Sarah C.;Lambe, Teresa;Pollard, Andrew J.;Nunes, Marta;Wuhrer, Manfred;Lauffenburger, Douglas A.;Madhi, Shabir A.;Alter, Galit
Despite the success of COVID-19 vaccines, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have emerged that can cause breakthrough infections. Although protection against severe disease has been largely preserved, the immunological mediators of protection in humans remain undefined. We performed a substudy on the ChAdOx1 nCoV-19 (AZD1222) vaccinees enrolled in a South African clinical trial. At peak immunogenicity, before infection, no differences were observed in immunoglobulin (Ig)G1-binding antibody titers; however, the vaccine induced different Fc-receptor-binding antibodies across groups. Vaccinees who resisted COVID-19 exclusively mounted FcγR3B-binding antibodies. In contrast, enhanced IgA and IgG3, linked to enriched FcγR2B binding, was observed in individuals who experienced breakthrough. Antibodies unable to bind to FcγR3B led to immune complex clearance and resulted in inflammatory cascades. Differential antibody binding to FcγR3B was linked to Fc-glycosylation differences in SARS-CoV-2-specific antibodies. These data potentially point to specific FcγR3B-mediated antibody functional profiles as critical markers of immunity against COVID-19. Kaplonek et al. provide a prospective look at ChAdOx1 nCoV-19-vaccinated individuals who go on to experience breakthrough COVID infections. They report an antibody Fc profile characterized by higher FcgR2b and reduced Fcgr3b for individuals who are more susceptible to breakthrough infections.
登录
查看更多内容
DOI:
10.1056/nejmoa2109072
发表时间:
2021-10-14
期刊:
The New England journal of medicine
影响因子:
--
作者:
Bergwerk M;Gonen T;Lustig Y;Amit S;Lipsitch M;Cohen C;Mandelboim M;Levin EG;Rubin C;Indenbaum V;Tal I;Zavitan M;Zuckerman N;Bar-Chaim A;Kreiss Y;Regev-Yochay G
通讯作者:
Regev-Yochay G
影响因子:
6.7
作者:
Crawford A;Angelosanto JM;Nadwodny KL;Blackburn SD;Wherry EJ
通讯作者:
Wherry EJ
影响因子:
29.7
作者:
Bournazos S;Wang TT;Dahan R;Maamary J;Ravetch JV
通讯作者:
Ravetch JV
DOI:
10.1111/j.2517-6161.1995.tb02031.x
发表时间:
1995-01-01
影响因子:
5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者:
HOCHBERG, Y
影响因子:
7.8
作者:
Alter G;Ottenhoff THM;Joosten SA
通讯作者:
Joosten SA